Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -254.9% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 2.6 | n/a |
Pr/Book | 0.3 |
Latest | F'cast | |
---|---|---|
Revenue | -45.0% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 11.47 | (3.43) | (8.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 277.20 | 165.17 | 194.00p | 4.4 | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 92.60 | (5.66) | (9.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 21.04 | (20.05) | (31.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 11.58 | (28.57) | (39.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Update re. Lab 21 HSE Prosecution | 18-Mar-2025 | 16:15 | RNS |
Liquidity Agreement and Total Voting Rights | 03-Mar-2025 | 15:00 | RNS |
IVDR accreditation for Yourgene QST*R Base assay | 20-Feb-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 42.15p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 118.00 |
52 Week Low | 40.30 |
Volume | 11,648 |
Shares Issued | 70.63m |
Market Cap | £29.77m |
Beta | 0.04 |
RiskGrade | 453 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:44 | 2,139 @ 40.30p |
12:46 | 3 @ 41.40p |
12:37 | 825 @ 40.35p |
12:30 | 3,486 @ 41.28p |
12:15 | 3 @ 41.00p |
You are here: research